The Deep Metabolism Assessment® (DMA®) technology is the revolutionary zero-invasive AI-native screening technology for early diagnosis and personalized medicine.

The DMA® device is able to identify altered biochemical reactions at the metabolic level within the human body, which are always linked to symptoms and diseases.

By analyzing these patterns, we gain valuable insights into early health indicators, enabling proactive care before diseases manifest or worsen.

The Deep Metabolism Assessment® (DMA®) technology is the revolutionary zero-invasive AI-native screening technology for early diagnosis and personalized medicine.

The DMA® device is able to identify altered biochemical reactions at the metabolic level within the human body, which are always linked to symptoms and diseases.

By analyzing these patterns, we gain valuable insights into early health indicators, enabling proactive care before diseases manifest or worsen.

Why Studying Metabolism is a Game-Changer

Metabolism is a complex network of chemical reactions that keeps our body functioning, enabling us to think, move and breathe. It adapts to various activities like eating, sleeping, and exercising to meet our body’s needs.

However, metabolism also responds to health challenges, shifting when organs are under stress or when inflammation occurs. These changes are often undetectable at first, as they happen at the cellular and biochemical levels without causing noticeable symptoms.

That’s where our DMA® technology comes in. It can detect these subtle changes by measuring electrical currents, capturing data at the nanoampere level.

By analyzing metabolism, we can uncover these hidden shifts, allowing for early diagnosis and intervention before conditions worsen.

The more we understand an individual’s metabolic profile, the better we can:

  • Assess their current health status.
  • Uncover the connections between causes and effects.
  • Provide tailored interventions to achieve the best outcomes.

This in-depth understanding of how organs function together enables us to take a holistic approach, ensuring care that is personalized, precise, and effective

By combining AI and advanced mathematical models, we developed a wide set of protocols and software, permitting us to correlate subsets of such measures to the status of specific organs, the Central Nervous System (CNS) or glands.

A Multi-Version Approach to Personalized HealthcareDMA® Technology for Screening, Diagnostics, Performance, and Monitoring.

The DMA® (Deep Metabolism Assessment®) technology offers four distinct versions, each designed to address specific needs in the realm of health screening, diagnostics, performance optimization, and monitoring.

At this stage, we are focusing on the go-to-market strategy for DMA® Screening, with plans to develop and roll out the other versions in the near future.

DMA® Screening is the cornerstone of this technology, offering in-depth metabolic analysis for early detection of health issues and enabling personalized care through advanced AI-driven insights.

DMA® Screening

Description:
DMA® Screening is an advanced metabolic analysis tool that enables molecular biologists and physiologists to thoroughly assess biochemical processes within the human body. This technology identifies significant metabolic patterns linked to health conditions and diseases, enabling early detection and prevention of potential health issues before they manifest clinically.

Technology User:
Biologists specializing in molecular biology and physiology.

End User (Patient):
Individuals undergoing health screenings, those following specific diets or supplement programs, or anyone seeking proactive health monitoring.

Output:
Detailed reports highlighting key metabolic patterns, offering insights into how biochemical processes correlate with overall health. These insights help clinicians identify early signs of potential health issues and tailor preventative strategies.

DMA® Diagnostic

Description:
DMA® Diagnostic is a diagnostic tool designed to detect specific metabolic patterns associated with various diseases. Each protocol targets a particular disease or disease subclass, providing probabilities and metabolic profiles to help clinicians assess whether a patient’s metabolic data aligns with specific conditions, such as hyperthyroidism or bacterial infections.

Technology User:
Healthcare professionals, including physicians and specialists.

End User (Patient):
Patients requiring specific diagnoses for conditions like metabolic disorders, infections, or chronic diseases.

Output:
Comprehensive diagnostic reports that present the likelihood of specific metabolic patterns aligning with a particular disease. These reports help physicians make accurate diagnoses and guide targeted treatment plans.

DMA® Performance

Description:
DMA® Performance is a specialized tool designed to assess metabolic factors influencing physical and cognitive performance. This technology includes protocols that support personalized programs for training, nutrition, and supplementation, tailored for individuals subject to high physical and mental stress.

Technology User:
Sports medicine professionals, biologists, psychologists, and fitness experts.

End User (Patient):
Athletes, high-performance professionals (e.g., pilots, military), emergency responders, managers and individuals undergoing extreme mental or physical stress.

Output:
Detailed assessments of metabolic performance, offering recommendations for optimizing physical capabilities, managing stress, and enhancing overall resilience and recovery in demanding environments.

DMA® Monitoring

Description:
DMA® Monitoring is designed for continuous tracking of metabolic parameters over time, offering two modes: low-frequency monitoring for periodic, self-managed measurements (e.g., daily or intra-daily) and high-frequency monitoring for clinical settings, where patients require frequent, real-time data collection.

Technology User:
Biologists, clinicians, and healthcare providers.

End User (Patient):
Patients needing ongoing metabolic monitoring, those on long-term treatment regimens, or individuals with chronic health conditions requiring regular assessment.

Output:
Metabolic data presented at regular intervals, enabling real-time tracking of physiological changes. These insights assist healthcare providers in making timely clinical decisions and ensuring optimal care and therapeutic management.

Patents & Certification

  • CE Certification for Electromagnetic Compatibility completed.

The DMA® technology  meets the safety, health, and environmental protection requirements established by the regulations of the European Union (CE for Electromagnetic Compatibility) The CE (electromagnetic compatibility) certification obtained, with the support of the MISTER Consortium (CNR – National Research Council) and the test laboratory ELICA.

  • EU Class 1 Medical Device: ongoing, expected to be completed by end of 2024, with the support of a specialized consulting firm.

The Class I a Medical Device certification confirms that a medical device complies with the safety and quality requirements established by the European MDR Regulation (2017/745). This classification is designated for non-invasive devices with minimal risk to the patient, often used to support diagnostic or therapeutic functions. Class I a devices must be designed and manufactured according to strict standards to ensure reliability and accuracy while safeguarding user health.

  • EU Class 2 Medical Device: planned for the first quarter of 2025

The Class II a Medical Device certification confirms that a medical device complies with the safety and quality requirements established by the European MDR Regulation (2017/745). This classification applies to moderate-risk devices, often used for diagnostic or therapeutic purposes involving direct or prolonged contact with the human body.Class II a devices undergo a more rigorous assessment compared to Class I devices to ensure their safe and effective use while adhering to high standards of design and manufacturing.

  • FDA Medical Device: planned for the fourth quarter of 2025.

The FDA Medical Device certification is the process by which a medical device is approved by the U.S. Food and Drug Administration (FDA), demonstrating compliance with the safety, efficacy, and quality requirements under U.S. regulations. The FDA categorizes devices into three classes (Class I, II, and III) based on the associated risk level, with increasingly stringent regulatory requirements.This certification is mandatory for marketing medical devices in the U.S. and involves procedures such as device registration, clinical performance reviews, and manufacturing process inspections.

To benefit from DMA® Technology, we are developing specialized Human Biology Institutes and partnering with  hospital, medical center, pharmacy or private clinic that interested in offering DMA® visits.